Lipella Pharmaceuticals I... (LIPO)
NASDAQ: LIPO
· Real-Time Price · USD
0.59
-0.00 (-0.17%)
At close: Sep 05, 2025, 9:32 AM
-0.17% (1D)
| Bid | 0.59 |
| Market Cap | 2.73M |
| Revenue (ttm) | 216.37M |
| Net Income (ttm) | -1.31B |
| EPS (ttm) | -3.33 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -0.03 |
| Analyst | n/a |
| Ask | 0.64 |
| Volume | 20 |
| Avg. Volume (20D) | 23,674 |
| Open | 0.59 |
| Previous Close | 0.59 |
| Day's Range | 0.59 - 0.59 |
| 52-Week Range | 0.55 - 7.31 |
| Beta | -0.09 |
About LIPO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LIPO
Website n/a
6 months ago
+41.64%
Lipella Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
7 months ago
+80.23%
Lipella Pharmaceuticals shares are trading higher after the company received FDA approval for an expanded access program for LP-310 in oral lichen planus.
